|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to cash used in operating activities: | ||||
| Depreciation and amortization | ||||
| Asset impairment due to restructuring | ||||
| Stock-based compensation expense | ||||
| Amortization (accretion) on investments | ||||
| Deferred tax liabilities | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses and other current assets | ||||
| Operating leases, net | ||||
| Accounts payable | ||||
| Accrued expenses and other liabilities | ||||
| Cash used in operating activities | ||||
| Investing activities | ||||
| Purchases of equipment | ||||
| Software development costs | ||||
| Purchases of investments | ||||
| Proceeds from sale or maturity of investments | ||||
| Cash provided by (used in) investing activities | ||||
| Financing activities | ||||
| Proceeds from public offering of common stock, net of issuance costs | ||||
| Proceeds from the exercise of stock options | ||||
| Payment of deferred offering costs | ||||
| Cash provided by financing activities | ||||
| Net change in cash, cash equivalents, and restricted cash | ||||
| Cash, cash equivalents, and restricted cash at beginning of year | ||||
| Cash, cash equivalents, and restricted cash at end of period | ||||
| Supplemental disclosure of noncash activities | ||||
| Conversion of redeemable convertible preferred stock to common stock | ||||
| Accretion of redeemable preferred stock to redemption value | ||||
| Property and equipment additions in accounts payable | ||||
| Right-of-use assets obtained in exchange for operating lease liabilities | ||||
| Operating cash flows used in operating leases | ||||
Loading...
